Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic

•This review summarises the impact of SARS-CoV-2 on interventions for type 1 diabetes in the UK.•The COVID-19 pandemic may shape the future of diabetes care forever.•The widening technological inequity needs resolution through targeted measures. This review considers the impact of the SARS-CoV-2 pan...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2022-03, Vol.185, p.109777-109777, Article 109777
Main Authors: Sathyanarayanan, A., Crabtree, T., Choudhary, P., Elliott, J., Evans, M.L., Lumb, A., Wilmot, E.G.
Format: Article
Language:English
Subjects:
Blood Glucose
Blood Glucose Self-Monitoring
COVID-19 - epidemiology
Diabetes Mellitus
Diabetes Mellitus, Type 1 - epidemiology
Diabetes Mellitus, Type 1 - therapy
Digital Divide
Evidence-Based Medicine
Humans
Pandemics - prevention & control
Quality of Life
Remote Consultation
SARS-CoV-2
Type 1
United Kingdom - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•This review summarises the impact of SARS-CoV-2 on interventions for type 1 diabetes in the UK.•The COVID-19 pandemic may shape the future of diabetes care forever.•The widening technological inequity needs resolution through targeted measures. This review considers the impact of the SARS-CoV-2 pandemic on access to interventions for those living with type 1 diabetes and discusses the solutions which have been considered and actioned to ensure ongoing access care. We performed a focussed review of the published literature, and the guidelines for changes that have been effected during the pandemic. We also drew from expert recommendations and information about local practice changes for areas where formal data have not been published. Evidence based interventions which support the achievement of improved glucose levels and/or reduction in hypoglycaemia include group structured education to support self-management, insulin pump therapy and continuous glucose monitoring. The SARS-CoV-2 pandemic had impacted the ability of diabetes services to deliver these intervention. Multiple adaptations have been put in place – transition to online delivery of education and care, and usage of diabetes technology. Although various adaptations have been made during the pandemic that have positively influenced uptake of services, there are many areas of delivery that need immediate improvement in the UK. We recommend a proactive approach in recognising the digital divide and inequity in distribution of these changes and we recommend introducing measures to reduce them.
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2022.109777